학술논문

First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device.
Document Type
Case Study
Source
Case Reports in Cardiology. 4/24/2024, Vol. 2024, p1-6. 6p.
Subject
*CARDIO-renal syndrome
*ACCELERATION (Mechanics)
*SPEED
*HEART assist devices
Language
ISSN
2090-6404
Abstract
Aortix™ is a novel percutaneous mechanical circulatory support device designed to facilitate diuresis in patients with cardiorenal syndrome. We describe for the first time the development of end-organ hypoperfusion from excess blood acceleration at the nominal setting and demonstrate through temporal-perfusion marker curves, the potential for speed modulation to optimize results. This will inform future device development and investigation of patient-specific device titration. [ABSTRACT FROM AUTHOR]